BioSpace News Archive

The alliance will catalyze the development of novel therapeutics coming from the research labs of Columbia University and accelerate these discoveries toward clinical validation in patients.

The idea of manipulating one’s memory has always been a popular concept among both researchers as well as the average person.

Bavarian Nordic A/S announced that the Data and Safety Monitoring Board confirmed a partial response in one of the first chordoma patients recruited and treated with the combination of BN-Brachyury and radiation treatment at the first evaluation timepoint.

Heidelberg Pharma AG announced that it has received a milestone payment of 250 TUSD from its cooperation partner Telix Pharmaceuticals Limited, Melbourne, Australia,.

dataTaker Automates Temperature Monitoring of Freezers A hospital required a continuous temperature monitoring system in order to measure and record the temperature of 50 freezers storing temperature-sensitive life science products.

InflaRx reported the top-line results of the international SHINE Phase IIb study, investigating the safety and efficacy of IFX-1, a first-in-class anti-human complement factor C5a monoclonal antibody, in patients suffering from moderate to severe Hidradenitis Suppurativa (HS), a painful and debilitating chronic inflammatory skin disease with limited treatment options.

The funding will be used to advance clinical development of its lead asset, a treatment for loculated pleural effusions, which is a serious complication of pneumonia.

Companies from across the globe share updates on their pipelines and growth strategies.

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, announced that it starts exclusive sales of NeuroStar® Transcranial Magnetic Stimulation in 5 June, which was first listed under coverage of Japanese national health insurance as the TMS device for depression on 1 June.

Evotec SE announced that its strategic alliance with Celgene Corporation has been expanded to include a new cell type triggering a payment of $ 9.0 m to Evotec.